
A study that prompted hope for a COVID-19 treatment in the early days of the pandemic has now been formally retracted by the scientific journal that published it.
Hydroxychloroquine, an antimalarial drug also approved for use in some autoimmune diseases, was first introduced to the world as a potential cure through a March 2020 study of 36 patients with COVID in the International Journal of Antimicrobial Agents. Elsevier, which owns the journal, issued its formal retraction on Tuesday.